K-numberK231424
Device nameHeartBeam AIMIGo(TM) System
ApplicantHeartbeam, Inc.
Product codeMWJ
Device classClass II
Decision dateDec 13, 2024
DecisionSubstantially Equivalent
Regulation870.2800
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The HeartBeam AIMIGo System is a portable, non-invasive ECG recorder that captures a 3-lead electrocardiogram from 5 electrodes for adults in clinical or home settings. It records, stores, and transmits ECG data to a cloud server for physician review and manual interpretation of non-life-threatening arrhythmias, but does not perform automated cardiac analysis.

Technological characteristics

The device records 3 channels using 5 dry electrodes with a 30-second duration at 0.5–40 Hz frequency response, powered by a rechargeable lithium-ion battery. It differs from the predicate KardiaMobile 6L (which uses 1–2 channels and 3 dry electrodes) but is similar to the reference device VectraPlex ECG (which supports 3 or 12 channels and 5 or 10 electrodes). Both the subject device and predicate are prescription-use, non-single-use devices for adults.

Test standards cited

Software verification per IEC 62304:2006; ECG acquisition and transmission per IEC 60601-2-47:2012; biocompatibility per ISO 10993-1:2018; electromagnetic compatibility and electrical safety per IEC 60601-1:2012, IEC 60601-1-2:2014, and IEC 60601-1-11:2015; usability per IEC 62366-1.

Substantial equivalence argument

Although the AIMIGo uses 3 channels from 5 electrodes (versus the predicate's 1–2 channels from 3 electrodes), this difference is reconciled by reference to the VectraPlex ECG, which also acquires 3-lead data. The device has identical intended use, patient population, regulatory classification, and prescription-only status as the predicate. Nonclinical bench testing and clinical equivalence studies (pivotal study and device positioning validation) demonstrated that ECG waveforms from the 3-lead AIMIGo are clinically equivalent to standard 12-lead ECG for arrhythmia interpretation. These design and performance differences do not raise new safety or effectiveness questions compared to the predicate.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →